Odelia B Cooper

Title(s)HS Associate Clinical Professor, Medicine
Address760 Westwood Plaza 32-144
Los Angeles CA 90024
Phone(310) 423-4774
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. EGFR/ErbB2-Targeting Lapatinib Therapy for Aggressive Prolactinomas. J Clin Endocrinol Metab. 2021 Jan 23; 106(2):e917-e925. Cooper O, Bonert VS, Rudnick J, Pressman BD, Lo J, Salvatori R, Yuen KCJ, Fleseriu M, Melmed S. PMID: 33150390.
      View in: PubMed   Mentions:
    2. Dopamine Agonists for Pituitary Adenomas. Front Endocrinol (Lausanne). 2018; 9:469. Cooper O, Greenman Y. PMID: 30186234.
      View in: PubMed   Mentions:
    3. Silent corticotroph adenomas. Pituitary. 2018 Apr; 21(2):183-193. Ben-Shlomo A, Cooper O. PMID: 29344907.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    4. Role of tyrosine kinase inhibitors in the treatment of pituitary tumours: from bench to bedside. Curr Opin Endocrinol Diabetes Obes. 2017 Aug; 24(4):301-305. Ben-Shlomo A, Cooper O. PMID: 28520590.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    5. Long-Term Endocrine Outcomes Following Endoscopic Endonasal Transsphenoidal Surgery for Acromegaly and Associated Prognostic Factors. Neurosurgery. 2017 Aug 01; 81(2):357-366. Babu H, Ortega A, Nuno M, Dehghan A, Schweitzer A, Bonert HV, Carmichael JD, Cooper O, Melmed S, Mamelak AN. PMID: 28368500.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    6. Sellar and clival plasmacytomas: case series of 5 patients with systematic review of 65 published cases. Pituitary. 2017 Jun; 20(3):381-392. Lee J, Kulubya E, Pressman BD, Mamelak A, Bannykh S, Zada G, Cooper O. PMID: 28251542.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    7. Altered Pituitary Gland Structure and Function in Posttraumatic Stress Disorder. J Endocr Soc. 2017 Jun 01; 1(6):577-587. Cooper O, Bonert V, Moser F, Mirocha J, Melmed S. PMID: 29264511.
      View in: PubMed   Mentions:
    8. Silent corticotroph adenomas. Pituitary. 2015 Apr; 18(2):225-31. Cooper O. PMID: 25534889.
      View in: PubMed   Mentions:
    9. ErbB receptor-driven prolactinomas respond to targeted lapatinib treatment in female transgenic mice. Endocrinology. 2015 Jan; 156(1):71-9. Liu X, Kano M, Araki T, Cooper O, Fukuoka H, Tone Y, Tone M, Melmed S. PMID: 25375038.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    10. A structural and functional acromegaly classification. J Clin Endocrinol Metab. 2015 Jan; 100(1):122-31. Cuevas-Ramos D, Carmichael JD, Cooper O, Bonert VS, Gertych A, Mamelak AN, Melmed S. PMID: 25250634.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    11. Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors. Endocrine. 2014 Jun; 46(2):318-27. Cooper O, Mamelak A, Bannykh S, Carmichael J, Bonert V, Lim S, Cook-Wiens G, Ben-Shlomo A. PMID: 24287797.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    12. Single-surgeon fully endoscopic endonasal transsphenoidal surgery: outcomes in three-hundred consecutive cases. Pituitary. 2013 Sep; 16(3):393-401. Mamelak AN, Carmichael J, Bonert VH, Cooper O, Melmed S. PMID: 23011322.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    13. Bisphosphonate drug holiday: choosing appropriate candidates. Curr Osteoporos Rep. 2013 Mar; 11(1):45-51. Ro C, Cooper O. PMID: 23296595.
      View in: PubMed   Mentions:
    14. Ectopic acromegaly due to growth hormone releasing hormone. Endocrine. 2013 Apr; 43(2):293-302. Ghazi AA, Amirbaigloo A, Dezfooli AA, Saadat N, Ghazi S, Pourafkari M, Tirgari F, Dhall D, Bannykh S, Melmed S, Cooper O. PMID: 22983831.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    15. Subclinical hyperfunctioning pituitary adenomas: the silent tumors. Best Pract Res Clin Endocrinol Metab. 2012 Aug; 26(4):447-60. Cooper O, Melmed S. PMID: 22863387.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    16. EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas. J Clin Invest. 2011 Dec; 121(12):4712-21. Fukuoka H, Cooper O, Ben-Shlomo A, Mamelak A, Ren SG, Bruyette D, Melmed S. PMID: 22105169.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansAnimalsCells
    17. Expression and function of ErbB receptors and ligands in the pituitary. Endocr Relat Cancer. 2011 Oct; 18(6):R197-211. Cooper O, Vlotides G, Fukuoka H, Greene MI, Melmed S. PMID: 21917845.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimals
    18. HER2/ErbB2 receptor signaling in rat and human prolactinoma cells: strategy for targeted prolactinoma therapy. Mol Endocrinol. 2011 Jan; 25(1):92-103. Fukuoka H, Cooper O, Mizutani J, Tong Y, Ren SG, Bannykh S, Melmed S. PMID: 21106881.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    19. Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes. Horm Cancer. 2010 Apr; 1(2):80-92. Cooper O, Ben-Shlomo A, Bonert V, Bannykh S, Mirocha J, Melmed S. PMID: 20717480.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    20. Heregulin regulates prolactinoma gene expression. Cancer Res. 2009 May 15; 69(10):4209-16. Vlotides G, Cooper O, Chen YH, Ren SG, Greenman Y, Melmed S. PMID: 19401448.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    21. Ovarian hyperstimulation syndrome caused by an FSH-secreting pituitary adenoma. Nat Clin Pract Endocrinol Metab. 2008 Apr; 4(4):234-8. Cooper O, Geller JL, Melmed S. PMID: 18268519.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    22. Opiate drug use: a potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease. Clin Infect Dis. 2003; 37 Suppl 2:S132-6. Cooper OB, Brown TT, Dobs AS. PMID: 12942387.
      View in: PubMed   Mentions:
    23. D-aspartate localizations imply neuronal and neuroendocrine roles. Proc Natl Acad Sci U S A. 1997 Mar 04; 94(5):2013-8. Schell MJ, Cooper OB, Snyder SH. PMID: 9050896.
      View in: PubMed   Mentions: 37     Fields:    Translation:Animals
    Odelia's Networks
    Concepts (120)
    Derived automatically from this person's publications.
    Co-Authors (5)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department